Detalhe da pesquisa
1.
HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression.
Nucleic Acids Res
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597676
2.
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis.
Blood
; 141(21): 2615-2628, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735903
3.
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.
Blood
; 141(4): 391-405, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126301
4.
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity.
J Transl Med
; 22(1): 208, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413989
5.
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification.
Haematologica
; 109(1): 231-244, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439377
6.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439329
7.
Tagraxofusp in myeloid malignancies.
Hematol Oncol
; 42(1): e3234, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846131
8.
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort.
Hematol Oncol
; 42(1): e3249, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287529
9.
Teclistamab-cqyv in multiple myeloma.
Eur J Haematol
; 112(3): 320-327, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848191
10.
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications.
Eur J Haematol
; 112(6): 860-869, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294126
11.
Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88.
Blood
; 137(18): 2495-2508, 2021 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33197938
12.
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity.
Blood
; 138(18): 1705-1720, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077955
13.
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins.
Haematologica
; 108(1): 219-233, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073514
14.
Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma.
Haematologica
; 108(12): 3333-3346, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381763
15.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632738
16.
Myelodysplastic syndromes with ring sideroblasts.
Hematol Oncol
; 41(4): 612-620, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794650
17.
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.
Ann Hematol
; 102(6): 1409-1420, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37079068
18.
Iron chelation therapy.
Eur J Haematol
; 110(5): 490-497, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708354
19.
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma.
Int J Mol Sci
; 24(19)2023 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37834003
20.
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Blood
; 135(21): 1859-1869, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267500